“EVALUATE THE CONCENTRATION OF SERUM CFDNA AND INTEGRITY AS A NON-INVASIVE MARKER TO DISTINGUISH BETWEEN MALIGNANT AND BENIGN BREAST LESION”. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases, vol. 31, no. 1, Feb. 2024, pp. 366-89, https://jrdiabet.ro/index.php/RJDNMD/article/view/304.